This is one of a number of bulletins providing further information on medicines contained in the DROP-List
(DRugs Of low Priority). This bulletin focuses on omega-3 fatty acids and provides the rationale for therapy to be stopped or for patients to be switched to alternative agents and for new patients not to be started on omega-3 fatty acids.
Omega-3 fatty acids
(subscribers will need to be logged in to view and download these documents)
Non-subscribers please note
Following the recent changes to the PrescQIPP programme access to this bulletin will be restricted to subscribers only. This resource will be made publicly available at the end of November. To find out more about the full benefits of subscribing to the PrescQIPP programme please visit: